← Leaderboards
Martin Akerman
Envisagenics, Inc.
$3,189,216
Attributed
$4,226,929
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2015–23$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,226,929 · 4
By mechanism
R44$3,700,427 · 2
R43$526,502 · 2
Top collaborators
- Gayatri Arun3 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMutationTranscriptome SequencingComputer SoftwareAlternative SplicingSmall Business Innovation Research GrantRna SplicingSamplingProtein IsoformsPerformanceCollaborationsRegulationEventLaboratoriesValidationTissuesAutomobile DrivingCommercializationBindingMessenger RnaHuman DiseaseCell SurfaceImmunooncologyDrug Discovery
Grant awards (8)
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data$980,257
R44 · FY2023 · CA · contact PI
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data$77,000
R44 · FY2023 · CA · contact PI
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data$1,018,170
R44 · FY2022 · CA · contact PI
SpliceCore: A Cloud-Based Software Platform to Translate Alternative Splicing Events into Therapeutic Targets Using RNA-seq Data$517,226
R44 · FY2019 · GM · contact PI
A Software Platform for the Identification of Cell Surface Antigens Using RNA-seq Data$301,502
R43 · FY2019 · CA · contact PI
SpliceCore: A Cloud-Based Software Platform to Translate Alternative Splicing Events into Therapeutic Targets Using RNA-seq Data$982,774
R44 · FY2018 · GM · contact PI
SpliceCore: A Cloud-Based Software Platform to Translate Alternative Splicing Events into Therapeutic Targets Using RNA-seq Data$125,000
R44 · FY2018 · GM · contact PI
SpliceCore: A cloud-based platform to detect, quantify and interpret alternative splicing variation from next-generation sequencing data.$225,000
R43 · FY2015 · GM · contact PI